Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9503]

Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible...

Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam...

Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible metastatic urothelial carcinoma ( Dr Michiel Simon van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )

HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCC

Dr David Braun - Yale School of Medicine, New Haven, USA

HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )

Tumour microenvironment and circulating biomarkers predict response to...

Dr David Braun - Yale School of Medicine, New Haven, USA

Tumour microenvironment and circulating biomarkers predict response to immunotherapy in advanced RCC ( Dr David Braun - Yale School of Medicine, New Haven, USA )

Catequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcoma

Prof Robin Lewis Jones - The Royal Marsden, London, UK

Catequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcoma ( Prof Robin Lewis Jones - The Royal Marsden, London, UK )

ASCO 2025: Metastatic breast cancer treatment highlights

Dr Maryam Lustberg - Yale School of Medicine, New Haven, USA

ASCO 2025: Metastatic breast cancer treatment highlights ( Dr Maryam Lustberg - Yale School of Medicine, New Haven, USA )

ctDNA-guided chemo escalation does not improve recurrence-free survival in...

Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia

ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancer ( Dr Jeanne Tie - Peter MacCallum Cancer Centre, Melbourne, Australia )

Disparities in mammogram screening amongst LGBTQ+ populations

Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA

Disparities in mammogram screening amongst LGBTQ+ populations ( Dr Manas Pustake - Texas Tech University Health Science Center, El Paso, USA )

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential...

Dr Ruben A. Mesa - Atrium Health Wake Forest Baptist Comprehensive Cancer...

Ropeginterferon Alfa-2b shows superior efficacy over anagrelide in essential thrombocythaemia ( Dr Ruben A. Mesa - Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, USA )

QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC

Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany

QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBC ( Prof Jens Bedke - Klinikum Stuttgart-Katharinenhospital, Stuttgart, Germany )

Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type...

Dr Veronica Conca - University of Pisa, Pisa, Italy

Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRC ( Dr Veronica Conca - University of Pisa, Pisa, Italy )

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer

Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany

Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancer ( Prof Sven Mahner - Ludwig Maximilian University of Munich, Munich, Germany )

New MOAs in prostate cancer treatment - what’s next?

Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini

New MOAs in prostate cancer treatment - what’s next? ( Dr Joaquin Mateo, Dr Andrew Parsonson and Dr Capucine Baldini )

More from ecancer